Cervical Cancer Market

In 2017, the total prevalent population of Cervical Cancer in 7MM was 43,514. The prevalent cases of Cervical Cancer in the United States in 2017 was 32.07% of the total prevalent cases.

The therapeutic market of Cervical Cancer in the 7MM was found to be USD 330.59 million in 2017.

The key players in the Cervical Cancer Market includes Seattle Genetics, Genmab, AstraZeneca, Zeria Pharmaceutical, Regeneron Pharmaceutical, Sanofi, Advaxis, Iovance Biotherapeutics, Agenus, Roche, Akeso Biopharma, Vaccibody and Altor BioScience.

For more detailed information on Cervical Cancer Market, visit:
https://www.delveinsight.com/report-store/cervical-cancer-market